ALLI ==> The Penn Quaker Winner

[mrmarket]

Allion Is to be purchased for 6.46 a share I paid 6.47. Can anyone tell me what happens now?

You're gonna get cash..hopefully another bidder comes in and it goes to $8.36

[RL]

What happens to my holdings In Allion

Allion Is to be purchased for 6.46 a share I paid 6.47. Can anyone tell me what happens now?

[tiedyed1]

ALLI being acquired for $6.60 cash

Thank you Ernie. While not exactly as planned, your writeup was very sound and I kept acquiring on the way down for a cost basis is 5.57. Today I am out with a 15%+ gain.


Allion Healthcare to be acquired for $6.60 a share
2:47a ET October 19, 2009 (MarketWatch)
TEL AVIV (MarketWatch) -- Allion Healthcare Inc., the Melville, N.Y., provider of specialty pharmacy and disease-management services, said late on Sunday that it definitively agreed to be acquired by an affiliate of HIG Capital LLC for $6.60 a share cash. The company valued the deal at about $199 million plus HIG, the Miami investment firm, will assume or repay $79 million of debt. On Friday, Allion shares closed at $5.44, indicating that HIG is paying a premium of 21%; the company noted that the deal price was 30% over the five-day average closing price before the deal was announced. Allion's directors unanimously approved the terms, and holders including Parallex LLC representing more than 41% of Allion's shares have agreed to vote for the deal. Raymond James advised Allion's board. Subject to antitrust clearance and other conditions, the company hopes to close the deal in the first quarter.

[tiedyed1]

If this was a cure I would say dump it. But the vaccine recently announced, statistically at this time, will protect about a third of those receiving it. How long will it be for this and other more effective vaccines to get some legs? While I do hope HIV can be prevented I see this recent news affecting ALLI sentiment but not fundamental bottom line for years to come.

Just my .02, but I think this is still one to accumulate at these lower levels and expect earnings and projections to remain in line which will get the sentiment back on track.

Not 4-6 weeks as hoped but fundamentals still ok.
I'm still in.
Thanks Ernie.

-Adam

[mrmarket]

I bought at 6.65 and 6.78 and sold yesterday at 6.67, I did not like the price action the last few days, it made lower lows a few days in a row, but
that is nothing compared to all the profits I've made thanks to the Huge maestro.

I think the news of the HIV vaccine, while great for the world, certainly may have a negative fundamental impact on ALLI's business in the long run. Could be profit taking by the longer term investors.

[yosberk]

Alli really took it on the chin today

I bought at 6.65 and 6.78 and sold yesterday at 6.67, I did not like the price action the last few days, it made lower lows a few days in a row, but
that is nothing compared to all the profits I've made thanks to the Huge maestro.

[wooish]

Mr. Market

You should copyright your statement "I still own it. What you do with your money is up to you." and "There is no advice" and of course "Mr. Market is huge"

[mrmarket]

I am wondering if I should buy more or just stick with what I have, I would love to get an update on ALLI.

I still own it. What you do with your money is up to you.

[yosberk]

skkinvest

I am wondering if I should buy more or just stick with what I have, I would love to get an update on ALLI.

[skkinvest]

Whats going on with ALLI

is it bull or bear ?? i have noe idia ..even the dow dons't look or feel good

[zombie]

Less than market expectation results:

Second Quarter Highlights

* Net sales increased 15.3% to $100 million from $86 million
* Specialty HIV net sales increased 9.4% to $75 million
* Specialty Infusion net sales increased 38.0% to $25 million
* Adjusted EBITDA grew 25.7% to $9.2 million, or 9.3% of sales
* Adjusted diluted earnings per share increased to $0.14 from $0.11

Allion Healthcare (NASDAQ: ALLI - News) today announced second quarter net income of $3.2 million, or $0.11 per share. Second quarter results include expenses totaling $954,000, or $0.03 per share, related to the Company’s adoption of EITF 07-05, which requires the Company to “mark to market” its outstanding stock warrants, and stock-based compensation expense from the issuance of phantom stock units. Second quarter results also include the full effect of the 2,624,990 shares issued as a result of the Biomed earn out.

[wooish]

Most traders I know would buy them at 2 separate batches.

[yosberk]

ALLI what is the strategy

I want to buy 2000 shears, should I buy it all at once or split the buy in four.
Thanks.
P.S Congratulation on your hot winning streak.

[Websman]

Just picked some up this morning at 7.4. This one is looking good!

7.42 and climbing...easy money!

[jiesen]

I'm in at 7.4

Just picked some up this morning at 7.4. This one is looking good!